| Code | Description | Claims | Beneficiaries | Total Paid |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
7,362 |
7,211 |
$1.70M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
31,962 |
28,379 |
$1.51M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,800 |
2,746 |
$944K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,888 |
8,243 |
$920K |
| 99070 |
|
30,454 |
14,238 |
$813K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
28,495 |
25,117 |
$671K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,997 |
6,240 |
$548K |
| 0450 |
Emergency room services |
9,573 |
8,616 |
$535K |
| J3490 |
Unclassified drugs |
24,568 |
11,214 |
$448K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,942 |
2,861 |
$405K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
4,641 |
4,321 |
$358K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,153 |
9,399 |
$338K |
| 80053 |
Comprehensive metabolic panel |
18,846 |
17,020 |
$337K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,296 |
2,193 |
$330K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,434 |
3,162 |
$275K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,008 |
4,576 |
$266K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,173 |
1,160 |
$248K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,218 |
21,693 |
$236K |
| 99199 |
Unlisted special service, procedure or report |
5,315 |
4,434 |
$233K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,725 |
2,452 |
$183K |
| 71045 |
Radiologic examination, chest; single view |
7,445 |
7,089 |
$171K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,338 |
2,276 |
$164K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
890 |
884 |
$163K |
| 84484 |
|
7,624 |
6,791 |
$156K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,900 |
1,790 |
$146K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
486 |
483 |
$141K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
429 |
402 |
$134K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,509 |
2,465 |
$131K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,943 |
7,059 |
$116K |
| 0250 |
|
4,526 |
2,779 |
$114K |
| 71046 |
Radiologic examination, chest; 2 views |
3,381 |
3,264 |
$111K |
| 59025 |
Fetal non-stress test |
3,550 |
1,175 |
$96K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,511 |
4,207 |
$88K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
98 |
96 |
$84K |
| 83880 |
|
2,314 |
2,174 |
$84K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,651 |
1,596 |
$82K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,650 |
1,595 |
$82K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,415 |
4,849 |
$79K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,823 |
2,471 |
$76K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
4,254 |
2,172 |
$75K |
| 87088 |
|
6,511 |
6,166 |
$75K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
982 |
965 |
$75K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
65 |
65 |
$73K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,356 |
3,087 |
$70K |
| 83690 |
|
6,687 |
6,271 |
$70K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
522 |
504 |
$61K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,143 |
428 |
$61K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
345 |
336 |
$58K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,584 |
2,533 |
$57K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
263 |
263 |
$53K |
| 87631 |
|
598 |
573 |
$53K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
486 |
446 |
$49K |
| 93971 |
|
399 |
393 |
$48K |
| 87040 |
|
1,866 |
1,745 |
$43K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
504 |
486 |
$43K |
| 0516 |
|
1,706 |
1,587 |
$41K |
| 81001 |
|
8,961 |
8,511 |
$41K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
500 |
482 |
$39K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,424 |
4,185 |
$38K |
| Z7502 |
|
1,091 |
1,032 |
$37K |
| 0456 |
|
1,123 |
1,025 |
$37K |
| 70498 |
|
145 |
145 |
$36K |
| 70496 |
|
118 |
118 |
$36K |
| 83735 |
|
3,592 |
3,212 |
$36K |
| 87634 |
|
450 |
440 |
$35K |
| 73562 |
|
1,180 |
1,118 |
$35K |
| 73610 |
|
1,058 |
1,015 |
$35K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,761 |
1,123 |
$33K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
582 |
542 |
$31K |
| 84703 |
|
2,810 |
2,627 |
$31K |
| 73630 |
|
917 |
864 |
$30K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,649 |
644 |
$30K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
367 |
182 |
$29K |
| 82553 |
|
1,882 |
1,685 |
$29K |
| 0002A |
|
709 |
709 |
$28K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
903 |
866 |
$28K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
136 |
105 |
$27K |
| 76830 |
Ultrasound, transvaginal |
320 |
310 |
$27K |
| 85379 |
|
1,745 |
1,703 |
$25K |
| Q3014 |
Telehealth originating site facility fee |
1,296 |
1,019 |
$24K |
| 87186 |
|
2,147 |
2,087 |
$23K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,108 |
1,013 |
$22K |
| 85027 |
|
3,031 |
2,521 |
$21K |
| 0001A |
|
714 |
714 |
$21K |
| 82962 |
|
3,644 |
3,031 |
$21K |
| 83605 |
|
1,466 |
1,370 |
$19K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,059 |
1,730 |
$18K |
| 76801 |
|
166 |
144 |
$18K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
94 |
87 |
$17K |
| 93458 |
|
13 |
13 |
$17K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
106 |
77 |
$16K |
| 90715 |
|
249 |
247 |
$15K |
| 99218 |
|
100 |
63 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
1,712 |
1,442 |
$14K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,643 |
1,495 |
$13K |
| 73030 |
|
420 |
414 |
$13K |
| Z7610 |
|
960 |
450 |
$13K |
| 87070 |
|
891 |
873 |
$10K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
102 |
88 |
$10K |
| 87077 |
|
1,081 |
1,051 |
$10K |
| 85610 |
|
2,029 |
1,852 |
$9K |
| 96367 |
|
119 |
110 |
$9K |
| 94760 |
|
788 |
679 |
$9K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
429 |
253 |
$8K |
| J2060 |
Injection, lorazepam, 2 mg |
1,320 |
1,175 |
$8K |
| 86900 |
|
1,205 |
1,112 |
$8K |
| 0270 |
|
1,370 |
608 |
$7K |
| 81003 |
|
2,632 |
2,516 |
$7K |
| 73110 |
|
233 |
224 |
$7K |
| 72100 |
|
230 |
229 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
718 |
706 |
$7K |
| 73130 |
|
175 |
165 |
$7K |
| 85730 |
|
996 |
959 |
$7K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
191 |
178 |
$6K |
| 81025 |
|
1,205 |
1,158 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
558 |
553 |
$6K |
| 80061 |
Lipid panel |
336 |
330 |
$5K |
| 86901 |
|
1,483 |
1,379 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
939 |
859 |
$5K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
14 |
12 |
$5K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
847 |
661 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
33 |
24 |
$5K |
| 87210 |
|
807 |
771 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
82 |
81 |
$4K |
| 71250 |
|
52 |
52 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
19 |
13 |
$4K |
| 86850 |
|
1,036 |
942 |
$4K |
| V2632 |
Posterior chamber intraocular lens |
35 |
27 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
24 |
24 |
$4K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
332 |
309 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
26 |
26 |
$4K |
| Z7500 |
|
106 |
94 |
$3K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
28 |
28 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
158 |
143 |
$3K |
| 94644 |
|
92 |
86 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
27 |
27 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
494 |
453 |
$3K |
| 74018 |
|
93 |
93 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
338 |
332 |
$3K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
14 |
14 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
112 |
98 |
$3K |
| 87430 |
|
220 |
202 |
$3K |
| 82248 |
|
359 |
346 |
$3K |
| 93017 |
|
26 |
26 |
$2K |
| 73140 |
|
82 |
82 |
$2K |
| 0003A |
|
49 |
49 |
$2K |
| 86140 |
|
269 |
260 |
$2K |
| 84439 |
|
166 |
163 |
$2K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
17 |
17 |
$2K |
| 70486 |
|
13 |
12 |
$2K |
| 73502 |
|
40 |
40 |
$2K |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
36 |
36 |
$2K |
| J1171 |
Injection, hydromorphone, 0.1 mg |
41 |
34 |
$2K |
| 97750 |
|
75 |
54 |
$2K |
| 84702 |
|
98 |
81 |
$2K |
| 71020 |
|
44 |
38 |
$1K |
| 99152 |
|
45 |
45 |
$1K |
| 97139 |
|
70 |
13 |
$1K |
| 82803 |
|
65 |
65 |
$1K |
| 71101 |
|
40 |
39 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
25 |
25 |
$1K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
36 |
36 |
$976.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
14 |
13 |
$938.50 |
| 85007 |
|
289 |
263 |
$909.47 |
| 73080 |
|
25 |
25 |
$863.57 |
| 86780 |
|
40 |
39 |
$852.73 |
| 0012A |
|
30 |
30 |
$851.70 |
| 81002 |
|
161 |
113 |
$820.51 |
| 0761 |
|
31 |
27 |
$748.42 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
15 |
15 |
$718.34 |
| 83540 |
|
85 |
82 |
$714.95 |
| 83520 |
|
51 |
43 |
$701.15 |
| 0011A |
|
40 |
40 |
$677.60 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
103 |
100 |
$676.82 |
| 0051A |
|
16 |
16 |
$640.00 |
| 85652 |
|
143 |
139 |
$637.99 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
66 |
30 |
$592.39 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
86 |
77 |
$559.79 |
| 80299 |
|
31 |
16 |
$554.62 |
| 83550 |
|
70 |
69 |
$515.16 |
| 87641 |
|
27 |
27 |
$500.65 |
| 0760 |
|
36 |
35 |
$490.84 |
| 0064A |
|
12 |
12 |
$480.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
293 |
227 |
$459.83 |
| 96376 |
|
14 |
13 |
$459.78 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12 |
12 |
$424.86 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13 |
13 |
$414.40 |
| 71010 |
|
20 |
17 |
$394.44 |
| 82948 |
|
87 |
64 |
$387.25 |
| 94729 |
|
13 |
12 |
$373.05 |
| 87205 |
|
78 |
78 |
$356.58 |
| 29125 |
|
13 |
13 |
$351.68 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
26 |
24 |
$280.84 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
26 |
26 |
$257.07 |
| 87340 |
|
12 |
12 |
$193.69 |
| 82550 |
|
31 |
26 |
$179.42 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
15 |
12 |
$178.38 |
| 82728 |
|
14 |
14 |
$176.28 |
| 84100 |
|
44 |
39 |
$134.80 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
16 |
16 |
$107.16 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
17 |
17 |
$106.60 |
| 86308 |
|
13 |
13 |
$75.39 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
16 |
16 |
$55.38 |
| J2704 |
Injection, propofol, 10 mg |
14 |
12 |
$44.32 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
16 |
15 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
51 |
42 |
$0.00 |